Taprizosin

CAS No. 210538-44-6

Taprizosin( —— )

Catalog No. M34440 CAS No. 210538-44-6

Taprizosin(UK-338003) is a selective and orally active α1-adrenoceptor antagonist for vasodilatation in the treatment of benign prostatic hyperplasia.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 851 In Stock
10MG 1169 In Stock
25MG 1786 In Stock
50MG 2399 In Stock
100MG 3162 In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Taprizosin
  • Note
    Research use only, not for human use.
  • Brief Description
    Taprizosin(UK-338003) is a selective and orally active α1-adrenoceptor antagonist for vasodilatation in the treatment of benign prostatic hyperplasia.
  • Description
    Taprizosin(UK-338003) is a selective and orally active α1-adrenoceptor antagonist for vasodilatation in the treatment of benign prostatic hyperplasia.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    GPCR/G Protein
  • Target
    Adrenergic Receptor
  • Recptor
    Adrenergic Receptor
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    210538-44-6
  • Formula Weight
    506.58
  • Molecular Formula
    C25H26N6O4S
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    NC=1C=2C(=C(OC)C(OC)=CC2N=C(N1)N3CC=4C(CC3)=C(NS(C)(=O)=O)C=CC4)C5=CC=CC=N5
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • MG 1

    MG 1 is a potent alpha-1 adrenergic receptor antagonist.

  • OPC-28326

    OPC-28326 is a specific an α2-adrenergic receptor antagonist and acts as a peripheral vasodilator. OPC-28326 inhibits α2A-, α2B- and α2C-adrenoceptors with Ki of 2040, 285, and 55?nM, respectively.

  • Imiloxan

    Imiloxan (RS-21361) is an α2 adrenergic receptor antagonist used in the treatment of major depressive disorder.